TREATMENT OF ESSENTIAL HYPERTENSION WITH BETA-ALKYLAMINES, ESPECIALLY DIBENZYLINE

被引:14
作者
BAKKE, JL
WILLIAMS, RH
机构
关键词
D O I
10.1016/0002-9343(53)90014-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:141 / 159
页数:19
相关论文
共 44 条
[21]  
JOSEPHS I. L., 1950, ANN WESTERN MED AND SURG, V4, P789
[22]  
KAPPERT VA, 1949, HELVET MED ACTA S22, V16, P1
[23]   THE REPORTED ADRENERGIC BLOCKING ACTION OF BETA-HALOETHYLAMMONIUM COMPOUNDS [J].
KERWIN, JF ;
HALL, GC ;
NICKERSON, M ;
GUMP, WS ;
MCLEAN, RA ;
FELLOWS, EJ ;
ULLYOT, GE .
SCIENCE, 1951, 113 (2934) :315-317
[24]   ADRENERGIC BLOCKING AGENTS .3. N-(ARYLOXYISOPROPYL)-BETA-HALOETHYLAMINES [J].
KERWIN, JF ;
HALL, GC ;
MILNES, FJ ;
WITT, IH ;
MCLEAN, RA ;
MACKO, E ;
FELLOWS, EJ ;
ULLYOT, GE .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (09) :4162-4168
[25]  
KINSEY D, 1949, ANN INT MED, V30, P291
[26]   DEATH FOLLOWING USE OF TETRAETHYLAMMONIUM CHLORIDE [J].
LASSER, RP ;
ROSENTHAL, N ;
LOEWE, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1949, 139 (03) :153-154
[27]  
LOCKET S, 1951, Br Med J, V1, P778
[28]   ORAL HEXAMETHONIUM BROMIDE IN ESSENTIAL HYPERTENSION [J].
MACKEY, WA ;
SHAW, GB .
BMJ-BRITISH MEDICAL JOURNAL, 1951, 2 (4726) :259-265
[29]  
NICKERSON M, 1947, J PHARMACOL EXP THER, V89, P167
[30]  
NICKERSON M, 1948, J PHARMACOL EXP THER, V93, P40